---
id: 102
title: Pre-Travel Consultation and Vaccinations
category: clinical_syndromes
subcategory: travel_medicine
tags: [travel-medicine, vaccines, yellow-fever, typhoid, malaria-prophylaxis, travelers-diarrhea]
difficulty: medium
---

## Question

What are key pre-travel considerations? Use the **"Destination-Specific Vaccines + Malaria Prophylaxis + Travelers' Diarrhea Prevention"** framework.

## Answer

### **Pre-Travel Vaccines:**

**Routine Vaccines (Update as Needed):**
- MMR, Tdap, varicella, influenza, COVID-19

**Travel-Specific Vaccines:**

| Vaccine | Indication | Notes |
|---------|------------|-------|
| **Yellow Fever** | **Sub-Saharan Africa, South America** | **Required** for entry to some countries; **live vaccine** (avoid if immunocompromised); valid **10 days after** first dose |
| **Typhoid** | South Asia, Africa, Latin America | **Oral (Ty21a):** 4 doses every other day (live); **Injectable (Vi):** Single IM dose |
| **Hepatitis A** | Most developing countries | **2 doses** (0, 6-12 months); protective after first dose |
| **Hepatitis B** | High-risk activities (medical work, sexual exposure) | **3 doses** (0, 1, 6 months); accelerated: 0, 7, 21 days |
| **Rabies** | High-risk exposures (rural Asia, Africa, animal contact) | **Pre-exposure:** 3 doses (0, 7, 21/28 days) |
| **Japanese Encephalitis** | Rural Asia (especially rice fields, pig farms) | **2 doses** (0, 28 days) |
| **Meningococcal (ACWY)** | Sub-Saharan Africa (meningitis belt), **Hajj pilgrimage** | **Required** for Hajj/Umrah |
| **Cholera** | High-risk humanitarian work | Rarely indicated |

### **Malaria Prophylaxis:**
(See malaria prophylaxis card 094 for details)

**First-line:** Atovaquone-proguanil (Malarone) or doxycycline
**Region-specific:** Chloroquine if sensitive area (Central America, Caribbean)

### **Travelers' Diarrhea Prevention:**

**Prevention:**
- **Food/water precautions:** "Boil it, cook it, peel it, or forget it"
- Avoid tap water, ice, raw foods, street vendors

**Prophylaxis (rarely indicated):**
- **Bismuth subsalicylate** 2 tabs QID (mild protection, not preferred)
- **Rifaximin** 200mg daily (not FDA-approved for prophylaxis)

**Self-Treatment (bring prescription):**
- **Azithromycin 1000mg × 1 dose** (or 500mg daily × 3 days) - **Preferred** (covers *Campylobacter*)
- **Loperamide** 4mg initial → 2mg after each loose stool (max 16mg/day) - **Avoid if fever/bloody diarrhea**

## Key Points

### **Yellow Fever Vaccine:**
- **Live vaccine** (contraindicated if immunocompromised, pregnant, age >60 with no prior YF vaccine)
- **Valid 10 days after** first dose (plan accordingly)
- **International Certificate of Vaccination** required for some countries

### **Typhoid Vaccine:**
- **Oral (Ty21a):** Complete 1 week before travel, revaccinate every 5 years
- **Injectable (Vi):** Single dose, revaccinate every 2 years
- **Efficacy:** 50-80% (food/water precautions still essential)

### **Rabies Pre-Exposure Prophylaxis:**
- **Indicated:** High-risk travel (rural Asia/Africa, animal contact, limited access to post-exposure care)
- **3 doses** (0, 7, 21/28 days)
- If exposed after pre-exposure prophylaxis: Only need 2 booster doses (no HRIG)

### **Clinical Pearls:**
- **Yellow fever:** Required for some countries, avoid if age >60 + never vaccinated (risk of viscerotropic disease)
- **Typhoid:** South Asia (especially Pakistan, India, Bangladesh)
- **Malaria prophylaxis:** Start before travel, continue after return
- **Travelers' diarrhea:** Azithromycin × 1 (empiric self-treatment)
- **Update routine vaccines** (MMR, Tdap, varicella)

## Sources

- [CDC Yellow Book 2024: Travel Medicine]
- [IDSA: Travelers' Diarrhea Guidelines 2024]

## Media

N/A
